$2.28
0.000.00%
Pre-Market: Dec 27, 6:05 PM EDT
Comments
Loading...
Procaps Gr (PROC) Forecast
NewsEarningsProcaps Gr (PROC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProcaps Gr (NASDAQ:PROC) Stock Quotes, Forecast and News Summary
Procaps Gr Stock (NASDAQ: PROC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Procaps Gr (PROC) stock?
You can purchase shares of Procaps Gr (NASDAQ:PROC) through any online brokerage.
Who are Procaps Gr (PROC) competitors?
Other companies in Procaps Gr’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), GH Research (NASDAQ:GHRS), Bioage Labs (NASDAQ:BIOA), Alumis (NASDAQ:ALMS) and Aquestive Therapeutics (NASDAQ:AQST).
What is the forecast, or price target, for Procaps Gr (PROC) stock?
Procaps Gr has a consensus price target of $4.50.
What is the current price for Procaps Gr (PROC)?
The stock price for Procaps Gr (NASDAQ: PROC) is $2.28 last updated December 30, 2024 at 4:00 PM EST.
Does Procaps Gr (PROC) pay a dividend?
There are no upcoming dividends for Procaps Gr.
When is Procaps Gr (NASDAQ:PROC) reporting earnings?
Procaps Gr’s Q1 earnings are confirmed for Saturday, February 15, 2025.
Is Procaps Gr (PROC) going to split?
There is no upcoming split for Procaps Gr.
What sector and industry does Procaps Gr (PROC) operate in?
Procaps Gr is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.